Skip to main content

Cardinal Health, Inc.

Financial Performance

Cardinal Health Revenue & Financials

Revenue

$254.2B (FY2026)

Market Cap

$56B

Net Income

$1.7B

Employees

63,900

What is Cardinal Health's revenue?

Cardinal Health had $254.2B in revenue for fiscal year 2026, up 14.2% from 2025. Net income was $1.7B.

Latest revenue
$254.2B (FY2026)
Year-over-year
+14.2%
Growth rate (CAGR)
7.7% over 9 years
Peak revenue
$254.2B (FY2026)
Years of data
10
Employees
63,900
What is Cardinal Health's operating income?
Cardinal Health reported operating income of $2.6B for fiscal year 2026. sec.gov
How much profit does Cardinal Health make?
Cardinal Health reported net income of $1.7B for fiscal year 2026. sec.gov
How many employees does Cardinal Health have?
Cardinal Health has about 63,900 employees.

Financial Analysis

Cardinal Health combines very large revenue with thin margins. Fiscal 2026 revenue was $254.2 billion, up 14% from $222.6 billion in fiscal 2025, driven by brand and specialty drug volume from existing customers. GAAP operating earnings were $2.6 billion, GAAP diluted EPS was $7.23, and net earnings attributable to Cardinal Health were about $1.7 billion. Non-GAAP diluted EPS rose 37% to $11.26 ($10.95 excluding the IEEPA tariff refund). Operating cash flow was $5.2 billion and adjusted free cash flow was $5.0 billion. The company repurchased $1.4 billion of stock in fiscal 2026 and the board added $5.0 billion to the buyback authorization in August 2026. Fourth-quarter fiscal 2026 revenue was $63.7 billion, up 6%. Cardinal Health is a colossal healthcare services and logistics company, maintaining a market valuation generally exceeding $25 billion.

Revenue Trend Analysis

YoY Change

+14.2%

9-Year CAGR

+7.7%

Peak Year

2026

Trend

Consistent Growth

Cardinal Health, Inc. has 10 full fiscal year figures on this page, compounding at +7.7% annually over 9 years. The most recent year saw a 14.2% increase versus the prior year. Annual revenue peaked in fiscal year 2026 at $254.2B. Of 9 comparable year-over-year steps, 8 showed growth and 1 showed a decline.

Annual revenue history

Fiscal YearRevenueOperating IncomeNet IncomeYoY ChangeSource
FY2026$254.2B$2.6B$1.7B+14.2%Cardinal Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2026-08-11)

Fiscal year ended 2026-06-30.

FY2025$222.6B$2.3B$1.6B-1.9%Cardinal Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2026-08-11)

Fiscal year ended 2025-06-30.

FY2024$226.8B$1.2B$852M+10.7%Cardinal Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2026-08-11)

Fiscal year ended 2024-06-30.

FY2023$205B$752M$330M+13.0%Cardinal Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2025-08-12)

Fiscal year ended 2023-06-30.

FY2022$181.3B-$607M-$938M+11.6%Cardinal Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2024-08-14)

Fiscal year ended 2022-06-30.

FY2021$162.5B$472M$611M+6.2%Cardinal Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2023-08-15)

Fiscal year ended 2021-06-30.

FY2020$152.9B-$4.1B-$3.7B+5.1%Cardinal Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2022-08-11)

Fiscal year ended 2020-06-30.

FY2019$145.5B$2.1B$1.4B+6.4%Cardinal Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2021-08-16)

Fiscal year ended 2019-06-30.

FY2018$136.8B$126M$256M+5.3%Cardinal Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2020-08-13)

Fiscal year ended 2018-06-30.

FY2017$130B$2.1B$1.3B—Cardinal Health, Inc. annual report (Form 10-K, SEC EDGAR, filed 2019-08-20)

Fiscal year ended 2017-06-30.

Click any row to see year details.

Cardinal Health, Inc. balance sheet and cash flow

Balance-sheet figures are as of each fiscal year end; cash-flow figures cover the fiscal year. Taken from the company's annual report on Form 10-K, linked on each row. Free cash flow here is operating cash flow less capital expenditures, calculated by CorpDigest.

Fiscal YearOperating cash flowCapital expendituresTotal assetsShareholders' equityFree cash flowSource
FY2026ended Jun 30, 2026$5.2B$649M$57.3B-$2.9B$4.5BForm 10-K
FY2025ended Jun 30, 2025$2.4B$547M$53.1B-$2.8B$1.9BForm 10-K
FY2024ended Jun 30, 2024$3.8B$511M$45.1B-$3.2B$3.3BForm 10-K
FY2023ended Jun 30, 2023$2.8B$481M$43.3B-$3B$2.4BForm 10-K
FY2022ended Jun 30, 2022$3.2B$387M$43.9B-$709M$2.8BForm 10-K
FY2021ended Jun 30, 2021$2.4B$400M$44.5B$1.8B$2BForm 10-K
FY2020ended Jun 30, 2020$2B$375M$40.8B$1.8B$1.6BForm 10-K
FY2019ended Jun 30, 2019$2.7B$328M$41B$6.3B$2.4BForm 10-K
FY2018ended Jun 30, 2018$2.8B$384M$40B$6.1B$2.4BForm 10-K
FY2017ended Jun 30, 2017$1.2B$387M$40.1B$6.8B$797MForm 10-K

Keep researching Cardinal Health

Cardinal Health Revenue and Financial FAQ

What was Cardinal Health's total annual revenue in recent fiscal years?

Cardinal Health, Inc. reported revenue of $254.2 billion for fiscal year 2026, up from $222.6 billion in fiscal 2025.

What is Cardinal Health's operating profit margin?

Cardinal Health operates with consolidated operating margins of approximately 1.0% to 1.5%, typical of high-volume pharmaceutical distribution, while generating between $2.0 billion and $2.8 billion in annual non-GAAP operating earnings.

How much annual operating cash flow does Cardinal Health produce?

Cardinal Health produces between $2.5 billion and $3.5 billion in annual operating cash flow, providing strong liquidity to fund capital expenditures, dividend distributions, share buybacks, and strategic healthcare acquisitions.

What is Cardinal Health's dividend track record and payout policy?

Cardinal Health is an S&P Dividend Aristocrat, having increased its quarterly cash dividend for more than 35 consecutive years. The company currently pays an annualized dividend of over $2.00 per share with a payout ratio of roughly 25% to 35% of non-GAAP net income.

How much revenue does the Pharmaceutical segment generate compared to Medical Products?

The Pharmaceutical and Specialty Solutions segment accounts for roughly 92% to 94% of total company revenues (over $200 billion), while the Global Medical Products and Distribution (GMPD) segment contributes the remaining 6% to 8% (approximately $16 billion to $18 billion).

What is Cardinal Health's market capitalization on the New York Stock Exchange?

Cardinal Health's market capitalization typically ranges between $25 billion and $35 billion, reflecting its steady cash-flow generation, strong specialty distribution growth, and disciplined balance sheet management.

How did Cardinal Health resolve its opioid litigation liabilities financially?

In 2021, Cardinal Health joined a nationwide comprehensive settlement with US state attorneys general alongside McKesson and Cencora, agreeing to pay up to $6.4 billion over an 18-year period to resolve historical opioid distribution claims.

How did the expiration of the OptumRx customer contract impact Cardinal Health?

The expiration of the OptumRx commercial distribution contract in June 2024 reduced revenue by approximately $30 billion, but because bulk distribution contracts carry minimal profit margins, Cardinal Health absorbed the transition while maintaining strong operating profit growth.

Did Cardinal Health pay a fine for the opioid crisis?

Yes, Cardinal Health, along with the other major distributors, agreed to a massive $21 billion national settlement for their role in failing to stop suspicious, massive shipments of highly addictive opioids to pharmacies.

Cite or embed this data

Using these figures? Please credit CorpDigest with a link.

Cite this page
CorpDigest. "Cardinal Health Revenue & Financials." CorpDigest, https://corpdigest.com/company/cardinal-health/financials.
Embed this data
<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Cardinal Health reported $254.2B in revenue (FY2026).</strong><br>Source: <a href="https://corpdigest.com/company/cardinal-health/financials" target="_blank" rel="noopener">CorpDigest — Cardinal Health financials</a></div>

Related Financial Audits

Compare revenue, net income, and market cap scale

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.